← Back to Search

Multidisciplinary Health Intervention for Blood Cancer

N/A

Waitlist Available

Led By Andrew S Artz

Research Sponsored by City of Hope Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Hematologic malignancy or disease as indication for HCT

>= 65 years at time of planned HCT infusion

Must not have

Prior allogeneic stem cell transplant

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 1 year

Awards & highlights

No Placebo-Only Group

Summary

This trial is studying a multidisciplinary intervention to help older adults with blood cancers who are planning a stem cell transplant. The intervention includes multiple healthcare professionals and is aimed at improving fitness and the ability to bounce back after transplant.

Who is the study for?

This trial is for older adults (65+) with blood cancers who are candidates for stem cell transplantation. Participants must be able to read English, Spanish, or Mandarin and consent to the study's requirements. Those with prior allogeneic transplants or conditions that make study procedures unsafe are excluded.

What is being tested?

The trial is testing a multidisciplinary approach involving various healthcare professionals aimed at improving fitness and recovery post-transplant in older adults. It includes health promotion activities, quality-of-life assessments, and questionnaires.

What are the potential side effects?

Since this trial focuses on non-medical interventions like health promotion and questionnaires rather than drugs or medical treatments, traditional side effects are not applicable. However, participants may experience fatigue or stress related to additional appointments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I need a stem cell transplant for my blood cancer.

Select...

I am 65 years or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have had a stem cell transplant from a donor.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Feasibility of multidisciplinary team (MDT) (met 90 percent threshould, yes / no)

Secondary study objectives

Dose intensity of resiliency bolstering

Functional independent survival (FIS)

Library of MDT-facilitated intervention

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive care (MDT-intervention)Experimental Treatment3 Interventions

Patients participate in the MDT-intervention including access to a HCT physician, a geriatrician, physical or occupational therapist, dietician, and a social worker for three months before HCT and up to 100 days after HCT.

0 / 3Eligibility criteria met